5.025

15.25% 0.665

Optimi Health Corp (OPTH)

Overview News Price History Discussions Forecast

Optimi Health Corp stock is traded at $5.025, with a volume of 651.06K. It is up +15.25% in the last 24 hours and up +0.00% over the past month. Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.

Previous Close:

$4.36

Open:

$4.6

24h Volume:

651.06K

Relative Volume:

10.37

Market Cap:

$28.27M

Revenue:

$257.00K

Net Income/Loss:

$-3.07M

P/E Ratio:

-5.2745

EPS:

-0.9527

Net Cash Flow:

$-1.40M

1W Performance:

+23.77%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$4.40

$5.75

1-Week Range:

$4.01

$5.75

52-Week Range:

$4.00

$6.20

Optimi Health Corp Stock (OPTH) Company Profile

Name

Optimi Health Corp

Sector

Healthcare (1104)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

OPTH's Discussions on Twitter

Compare OPTH vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPTH Optimi Health Corp	5.025	28.27M	257.00K	-3.07M	-1.40M	-0.9527
TAK Takeda Pharmaceutical Co Adr	15.63	49.39B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	8.96	39.55B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.48	36.66B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	78.71	33.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	536.59	22.78B	3.17B	1.29B	1.01B	27.09

Optimi Health Corp Stock (OPTH) Latest News

Jun 18, 2026

SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets - Benzinga

Jun 18, 2026

Jun 17, 2026

SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits

Jun 17, 2026

Jun 16, 2026

Inside the new tiny-dose psilocybin pills labs will test in studies - Stock Titan

Jun 16, 2026

Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat

Jun 16, 2026

Optimi Health completes production of microdose psilocybin products - Investing.com

Jun 16, 2026

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research - Yahoo Finance Australia

Jun 16, 2026

Jun 12, 2026

OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill

Jun 12, 2026

Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance

Jun 12, 2026

Jun 10, 2026

Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com Australia

Jun 10, 2026

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - GuruFocus

Jun 10, 2026

Optimi Health ships psilocybin to UK for clinical trial - Investing.com

Jun 10, 2026

Optimi Health Completes First Psilocybin Export to UK for Planned Phase 2 Trial - citybuzz -

Jun 10, 2026

Optimi Health exports psilocybin to UK for clinical trial By Investing.com - Investing.com South Africa

Jun 10, 2026

Optimi Health exports psilocybin to UK for clinical trial - Investing.com UK

Jun 10, 2026

Optimi Health Completes First Export of Psilocybin to UK - marketscreener.com

Jun 10, 2026

Optimi Health Corp. Completes First Export of Psilocybin to the UK for Phase 2 Clinical Trial - Quiver Quantitative

Jun 10, 2026

OPTH SEC FilingsOptimi Health 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 10, 2026

Jun 09, 2026